How much did JenaValve raise?

JenaValve raised $26.5 Million in a funding round on August 7, 2015.

Who are the decision-makers at JenaValve?

Fundz holds 1 contact at JenaValve, including the CEO . Names and contact details are shown to Fundz members.

Jena Valve Technology Inc reported raising $26.5 Million in an initial SEC Form D filing, from an offering of $26.5 Million

PRIVATEAug 07, 2015

Amount Raised

$26.5 Million

$26.5 Million sold, per SEC Form D (first sale Aug 7, 2015)

Round Type

Venture

IrvineManufacturingInformation TechnologyBiotechnologyHealthcareHealth CareMedical Device

Quick answer

JenaValve raised $26.5 Million in a funding round, dated August 7, 2015. JenaValve is based in Irvine, California, United States.

How much did JenaValve raise?: JenaValve raised $26.5 Million in a funding round on August 7, 2015.
What does JenaValve do?: JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR).
Where is JenaValve based and how big is it?: JenaValve is based in Irvine, California, United States.
Who are the decision-makers at JenaValve?: Fundz holds 1 contact at JenaValve, including the CEO . Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical Device around the same time

Companies in the same sectors as JenaValve that raised within 45 days of this round, from Fundz verified event records.

TransMedics Group raised $500K on September 21, 2015.
Procyrion raised $5.2M on July 13, 2015.
Senseonics raised $10M on August 11, 2015.
SPR Therapeutics raised $519K (Seed) on July 21, 2015.
GUIDED THERAPEUTICS INC raised $2.5M (Seed) on July 15, 2015.
ivWatch raised $2.1M (Seed) on September 18, 2015.

Who to call at JenaValve, and when

A new round usually means JenaValve is about to hire and buy. The teams that reach out first get the meeting.

An alert the day JenaValve raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at JenaValve, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at JenaValve. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

JenaValve

Location

Irvine, California, United States

About

JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System is the first and only device currently approved in the EU for the treatment of severe, symptomatic aortic regurgitation in patients that are deemed high-risk for surgical aortic valve replacement. The Trilogy System is also CE-Mark approved for treatment of severe, symptomatic aortic stenosis. In the US, JenaValve has completed enrollment of the ALIGN-AR IDE Clinical Trial which will support a future PMA submission. If approved, the Trilogy System would become the first and only TAVR system in the US indicated for the treatment of symptomatic, severe AR.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment JenaValve raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contactsJohn K., CEO hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for JenaValve's next move

See what Strategic adds

JenaValve raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.